Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents. - Wikidata - awgldk - TriplyDB

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

http://www.wikidata.org/entity/Q39732005

about

Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.New advances in antibiotic development and discovery.Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.Current challenges in treating MRSA: what are the options?Antimicrobial-resistant Streptococcus pneumoniae: trends and management.In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.In vitro activity of bioactive extracts from rare actinomycetes against multi-drug resistant Streptococcus pneumoniae.Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.

P2860

Q24535492-62727446-776A-45E4-BC75-DC7A2EDDC4B6 Q24548260-A18165B1-B459-4DF9-85CE-F7165BD89480 Q24650162-EFDCF917-ED99-4569-A898-458878AA11AE Q28235095-71247EBF-4074-434C-B21D-B85CA6733711 Q33722172-BDFAD8CB-5B13-4159-BB55-7F12E3828609 Q36065983-BD1F1CE5-CFA5-4027-B782-D96B35C3C302 Q36283731-182F710B-F3A5-4D34-8E85-71D33E7FE24E Q37291338-0F93CAC5-ED37-4BB4-A852-6EE8ABE2460D Q37291341-8477D9D7-83D6-4169-BB07-37EACF4849A9 Q37428616-820DBB19-89A5-463F-907F-F62B2E079805 Q37568895-DF95E623-005E-4490-BE65-9C3DA229DDA8 Q39526130-C1321FC6-1B70-46FC-98EC-B3B619350C03 Q40165383-52DF0E19-DACE-4A35-97DD-C02128700DB3 Q40165422-CCFDDF46-4365-460D-B4FA-5C90A87A67AC Q41005410-436AB414-367A-475F-BBBF-BE032F6C5E44 Q41816467-CD10E701-8A11-45A0-85D7-A4AF2C4E1E05 Q41847350-A82EEA25-A241-4FA0-BFA1-3EB46999BF5A

P2860

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

http://www.wikidata.org/entity/Q39732005

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Antipneumococcal and antistaph ...... ared to those of other agents.

@en

Antipneumococcal and antistaph ...... ared to those of other agents.

@nl

type

label

Antipneumococcal and antistaph ...... ared to those of other agents.

@en

Antipneumococcal and antistaph ...... ared to those of other agents.

@nl

prefLabel

Antipneumococcal and antistaph ...... ared to those of other agents.

@en

Antipneumococcal and antistaph ...... ared to those of other agents.

@nl

P1433

Q39732005-FA2943B7-46C3-43E7-90DC-4209355B8ACF

P1476

Q39732005-336B9BF2-AB1B-4352-8C75-BC081B472438

P2093

Q39732005-1CFB6E27-CF66-4C05-9A62-DAE3D6C75A5C

Q39732005-3DFFF87A-ABFB-4BA3-A9D5-AE4CC27FA86B

Q39732005-536421F9-1379-4776-8D00-7C5FC3F54D0B

Q39732005-55EF14BE-A09C-4D84-A64B-3EF0652B3FAB

Q39732005-725740AE-6287-4615-A209-89620A86856F

Q39732005-A48133BA-19CB-4067-B9FD-6CFFDD9C0A3A

P2860

Q39732005-004318BA-2917-4B32-B6F2-B91E4840686E

Q39732005-0498C1F6-0E19-4AA9-A90B-36A3EDF738EB

Q39732005-1432342B-5E2B-4446-AA23-34D0AC95BC8B

Q39732005-2FB3B86F-5163-4674-84DE-5AEB70180E62

Q39732005-31D1C4E3-0A2A-4B6D-A409-93D910ECB37F

Q39732005-35238683-756A-49EE-8FBD-BF92B311AF5F

Q39732005-469F3703-F624-48D8-AE1E-272220795AA8

Q39732005-4D70B748-88A6-41C6-8A7E-C12B42011C65

Q39732005-5C01498E-42CC-4B5B-9686-6664D67DDD23

Q39732005-650FCC0C-7787-4190-9942-2A904B84F690

P304

Q39732005-4FEF37CC-8A1D-4BED-B5E0-46B17E212852

P31

Q39732005-568EE194-01DC-446A-BF0C-3B266C5B3094

P356

Q39732005-FDDC3009-4DAF-46EC-94C0-427BC3734154

P407

Q39732005-736458BF-73C1-4317-850F-761B62EDF741

P433

Q39732005-11653D7E-8B6E-4890-8674-70A81979CD24

P478

Q39732005-C013F6AB-F38D-479B-8F21-EAA41560196F

P577

Q39732005-875D3039-AB7F-47EE-83FF-7E1CBAFE8453

P698

Q39732005-B834F1F5-41D4-4F36-9810-D6080DC1D2A7

P932

Q39732005-02538FD1-ED36-4E07-827C-288AD9A84AA4

P356

AAC.47.3.1148-1150.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antipneumococcal and antistaph ...... ared to those of other agents.

@en

P2093

Ashok Rattan

http://www.w3.org/2001/XMLSchema#string

Dianne B Hoellman

http://www.w3.org/2001/XMLSchema#string

Gengrong Lin

http://www.w3.org/2001/XMLSchema#string

Lois M Ednie

http://www.w3.org/2001/XMLSchema#string

Michael R Jacobs

http://www.w3.org/2001/XMLSchema#string

Peter C Appelbaum

http://www.w3.org/2001/XMLSchema#string

P2860

Oxazolidinones: a review

In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.

Optimal treatment of complicated skin and skin structure infections.

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections.

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci

Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams.

Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.

P304

1148-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.3.1148-1150.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12604559

http://www.w3.org/2001/XMLSchema#string

P932

149337

http://www.w3.org/2001/XMLSchema#string